Injective, a notable player in the crypto space, has just wrapped up a significant technical transition: the migration of its INJ token from Ethereum’s ERC-20 standard to a native version on its own blockchain, the Injective EVM. This shift, completed by July 22, 2026, marks a major step for the platform’s ecosystem, with Coinbase leading the charge in supporting this new format over its predecessor.
The transition, which started on July 20, allowed Coinbase users to experience a seamless 1:1 conversion of their holdings. Post-migration, you can now trade directly on the native Injective network, effectively making the ERC-20 version a relic of the past. Coinbase’s decision to end its support for ERC-20 INJ deposits and withdrawals emphasizes this new chapter for the token.
What’s the big deal with the migration?
This isn’t just a switch for tech’s sake. The move to the native Injective EVM chain means better access to decentralized finance (DeFi) applications and increased liquidity for users. If you’ve ever been frustrated with cross-chain compatibility and transaction times, this development might just make your day.
Injective has been laying the groundwork for this since its native EVM launched back in November 2025. The migration aligns with a series of strategic moves, including a partnership with Robinhood, which could make Injective’s offerings accessible to a broader audience. These were highlighted at the Injective Summit in Washington, D.C., last month.
